John Ellerton

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

Lewis R. Silverman, Erin P. Demakos, Bercedis L. Peterson et al. · Journal of Clinical Oncology · 2002 · 1.8K citations

Medicine, Internal Medicine, Pharmacotherapy +16

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

Manish R. Patel, John Ellerton, Jeffrey R. Infante et al. · The Lancet Oncology · 2017 · 588 citations · Full text

Medicine, Oncology, Urology +12

Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma

W. C. Wood, Ronald D. Hart, Anne Moore et al. · New England Journal of Medicine · 1994 · 582 citations · Full text

Medicine, Oncology, Breast Oncology +10

Impact of Azacytidine on the Quality of Life of Patients With Myelodysplastic Syndrome Treated in a Randomized Phase III Trial: A Cancer and Leukemia Group B Study

Alice B. Kornblith, James E. Herndon, Lewis R. Silverman et al. · Journal of Clinical Oncology · 2002 · 415 citations

Medicine, Oncology, Pharmacotherapy +17